Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical drugs with the greatest number of patents still in force. The number of patents covering […]
Source
Which pharmaceutical drugs have the most patents? Read Post »
Annual Drug Patent Expirations for ROCKLATAN Rocklatan is a drug marketed by Alcon Labs Inc and is included in one […]
Source
Annual Drug Patent Expirations for XEGLYZE Xeglyze is a drug marketed by Hatchtech and is included in one NDA. It […]
Source
New patent expiration for Hatchtech drug XEGLYZE Read Post »
Annual Drug Patent Expirations for RHOPRESSA Rhopressa is a drug marketed by Alcon Labs Inc and is included in one […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Sweden. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Sweden? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Austria? Read Post »
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA. […]
Source
New patent expiration for United Therap drug ORENITRAM Read Post »